BPC-157

Overview

BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of body protection compound found in human gastric juice. It consists of 15 amino acids and is one of the most extensively studied peptides in preclinical research models. BPC-157 is classified as a stable gastric pentadecapeptide due to its resistance to hydrolysis and enzymatic degradation.

Research Summary

Preclinical studies in animal models have investigated BPC-157 across multiple tissue types. Research in rodent models has examined its effects on tendon healing (Chang et al., 2011), gastric mucosal integrity (Sikiric et al., 1999), and connective tissue repair processes. In vitro studies have explored its interaction with growth factor signaling pathways, nitric oxide systems, and angiogenic processes. Animal model research has also examined its potential interactions with the dopaminergic system. All studies referenced are preclinical — no human clinical trials have been completed.

Proposed Mechanism of Action

Preclinical research suggests BPC-157 may interact with nitric oxide (NO) pathways, VEGF-mediated angiogenesis, and FAK-paxillin signaling cascades involved in cell migration and tissue remodeling. Studies in animal models indicate potential modulation of growth factor receptor expression.

Vendor Availability

Published Research References

References are provided for informational purposes. PeptiNox does not endorse or validate the conclusions of cited studies. All listed research pertains to preclinical or in vitro investigations unless otherwise noted.